KIR3DL3 recruits SHP-1 and SHP-2 phosphatases, which attenuate signaling pathways such as ERK1/2, AKT and NF-κB, leading to reduced immune cell activation and function, thereby facilitating tumor immune evasion (Wei et al. 2021). Here, KIR3DL3 is linked to neoplasm.